CooperCompanies Appoints Paul Keel to its Board of Directors
CooperCompanies has appointed Paul Keel as an independent director to its Board of Directors, effective July 1, 2026. Mr. Keel has experience as a CEO in the medical device sector, having served as President and CEO of Envista Holdings Corporation since 2024.
CooperCompanies, a global medical device company, has appointed Paul Keel to its Board of Directors effective July 1, 2026. Keel will also serve on the Audit Committee. He has been President and CEO of Envista Holdings Corporation since 2024 and previously served as CEO of Smiths Group plc. Keel has also held various leadership roles at 3M, General Mills, General Electric, Norwest Equity Partners, and McKinsey & Company. CooperCompanies is headquartered in San Ramon, CA, and has a workforce of over 15,000, selling products in over 130 countries. The company is focused on helping people through its two business units, CooperVision and CooperSurgical.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.